Clinical Trial Update: Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the safety and preliminary efficacy of donor-derived endothelial progenitor cells in patients with acute ischemic stroke; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Allogeneic Endothelial Progenitor Cells (endothelial progenitor cells)

Snippet

Sponsor: Allife Medical Science and Technology Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 1 | Status: COMPLETED